Letters Comparing HPV vaccines

HPV vaccine prices in Italy

BMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d6668 (Published 18 October 2011) Cite this as: BMJ 2011;343:d6668
  1. Livio Garattini, director1,
  2. Katelijne van de Vooren, researcher1,
  3. Gianluigi Casadei, visiting scientist1
  1. 1CESAV, Centre for Health Economics, “Mario Negri” Institute for Pharmacological Research, 24020 Ranica (BG), Italy
  1. lgarattini{at}marionegri.it

In contrast to what was reported in the editorial,1 both the bivalent (Cervarix) and the quadrivalent (Gardasil) vaccines are used in Italy for the campaign against cervical cancer. Most of the 20 Italian regions, which fund and implement vaccination programmes on their territory, ran single tenders to exploit potential competition between the two …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial